SCHEMBL6402122

SCHEMBL6402122

Fc1c(F)c(F)c(-c2cccc(-c3c(F)c(F)c(F)c(F)c3F)c2-c2c(F)c(F)c(F)c(F)c2F)c(F)c1F

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 1/20 0.31
▸ DPP4 P27487 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA7 P43166 1/20 0.31
▸ CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29006514 0.87 CA1 (0.41) CA1CA2CA7CA9
SCHEMBL476826 0.85 — —
SCHEMBL6250870 0.83 — —
SCHEMBL5800731 0.83 ANPEP (0.31) ANPEPDPP4
SCHEMBL1265890 0.83 — —
SCHEMBL25223032 0.81 MEN1 (0.35) —
SCHEMBL17747945 0.81 — —
Phosphine SCHEMBL6541978 0.81 — —
SCHEMBL16355406 0.78 MAOA (0.36) CA1CA2CA7CA9
SCHEMBL16127265 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3031856-B1 CROSSLINKABLE FLUORINATED ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOFa AGC INC (JP) 2019-07-10 — — EP claimed
US-10087128-B2 Fluorinated aromatic compound, method for its production, curable material, its cured product, and optical member AGC Inc. (JP) 2018-10-02 — — US claimed
US-10066077-B2 Crosslinkable fluorinated elastomer composition and crosslinked product thereof ASAHI GLASS COMPANY, LIMITED (JP) 2018-09-04 — — US claimed
EP-3031793-B1 FLUORINATED AROMATIC COMPOUND, METHOD FOR ITS PRODUCTION, CURABLE MATERIAL, ITS CURED PRODUCT, AND OPTICAL MEMBER ASAHI GLASS CO LTD (JP) 2018-03-21 — — EP claimed
EP-3031793-A1 FLUORINE-CONTAINING AROMATIC COMPOUND, METHOD FOR PRODUCING SAME, CURABLE MATERIAL, CURED PRODUCT THEREOF, AND OPTICAL MEMBER Asahi Glass Company, Limited (JP) 2016-06-15 — — EP claimed
EP-3031856-A1 FLUORINE-CONTAINING CROSSLINKABLE ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOF Asahi Glass Company, Limited (JP) 2016-06-15 — — EP claimed
US-20160137809-A1 CROSSLINKABLE FLUORINATED ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOF ASAHI GLASS COMPANY, LIMITED (JP) 2016-05-19 — — US claimed
US-20160137572-A1 FLUORINATED AROMATIC COMPOUND, METHOD FOR ITS PRODUCTION, CURABLE MATERIAL, ITS CURED PRODUCT, AND OPTICAL MEMBER ASAHI GLASS COMPANY, LIMITED (JP) 2016-05-19 — — US claimed
US-20230114706-A1 PLASTIC OPTICAL FIBER MANUFACTURING METHOD NITTO DENKO CORPORATION (JP) 2023-04-13 — — US disclosed
CN-115362397-A Method for manufacturing plastic optical fiber 日东电工株式会社 2022-11-18 — — CN disclosed
EP-3031856-B1 CROSSLINKABLE FLUORINATED ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOFa AGC INC (JP) 2019-07-10 — — EP disclosed
US-10087128-B2 Fluorinated aromatic compound, method for its production, curable material, its cured product, and optical member AGC Inc. (JP) 2018-10-02 — — US disclosed
US-10066077-B2 Crosslinkable fluorinated elastomer composition and crosslinked product thereof ASAHI GLASS COMPANY, LIMITED (JP) 2018-09-04 — — US disclosed
EP-3031793-B1 FLUORINATED AROMATIC COMPOUND, METHOD FOR ITS PRODUCTION, CURABLE MATERIAL, ITS CURED PRODUCT, AND OPTICAL MEMBER ASAHI GLASS CO LTD (JP) 2018-03-21 — — EP disclosed
EP-2769255-A1 MONOLITHIC POLYMER OPTICAL FIBER RIBBON Chromis Fiberoptics Inc. (US) 2014-08-27 — — EP disclosed
WO-2013059601-A1 MONOLITHIC POLYMER OPTICAL FIBER RIBBON CHROMIS FIBEROPTICS, INC. (US) 2013-04-25 — — WO disclosed
US-20050141834-A1 Optical fiber having sea and islands structure ASAHI GLASS COMPANY, LIMITED (JP) 2005-06-30 — — US disclosed
EP-0856523-B1 Process for the preparation of a metallocene catalyst system BASELL POLYOLEFINE GMBH (DE) 2004-07-14 — — EP disclosed
US-6177376-B1 REACTING METALLOCENE WITH ORGANOLITHIUM COMPOUND AND GRIGNARD COMPOUND, ACTIVATION, CONTACTING WITH SUPPORT TARGOR GMBH (DE) 2001-01-23 — — US disclosed
EP-0856523-A1 Process for the preparation of a metallocene catalyst system HOECHST AKTIENGESELLSCHAFT (DE) 1998-08-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137572-A1 FLUORINATED AROMATIC COMPOUND, METHOD FOR ITS PRODUCTION, CURABLE MATERIAL, ITS CURED PRODUCT, AND OPTICAL MEMBER AFF1, AFF2, AFF4 ANPEP 4686/4885DPP4 4657/4885CA1 716/4885
US-10087128-B2 Fluorinated aromatic compound, method for its production, curable material, its cured product, and optical member AFF1, AFF2, AFF4 ANPEP 4686/4885DPP4 4657/4885CA1 716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback